360575-67-3

Basic information

• Product Name: methyl 4,5-dichloro-1-benzothiophene-2-carboxylate
• Synonyms: Methyl-4,5-dichlor-1-benzothiophen-2-carboxylat
• CAS NO: 360575-67-3
• Molecular Formula: C₁₀H₆Cl₂O₂S
• Molecular Weight: 261.1244
• Mol File: 360575-67-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 372.433°C at 760 mmHg
• Flash Point: 179.041°C
• Density: 1.494g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.654
• CAS DataBase Reference: methyl 4,5-dichloro-1-benzothiophene-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4,5-dichloro-1-benzothiophene-2-carboxylate(360575-67-3)
• EPA Substance Registry System: methyl 4,5-dichloro-1-benzothiophene-2-carboxylate(360575-67-3)

Safety Data

• Hazardous Substances Data: 360575-67-3(Hazardous Substances Data)

Upstream product

• 95399-95-4 2,3-Dichloro-6-fluorobenzaldehyde 
• 2365-48-2 Methyl thioglycolate 

Relevant articles and documents

METHOD FOR PROMOTING PLANT GROWTH

The present invention provides a method for promoting plant growth, which comprises treating a plant with a compound represented by the following Formula (1): provided that a method for promoting plant growth which comprises treating plants with a compound corresponding to any one of the following (1) to (8) is excluded: (1) Methyl 4-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (2) Methyl 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (3) Methyl 6-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (4) Methyl 7-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (5) Ethyl 4-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (6) Ethyl 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, (7) Ethyl 6-(trifluoromethyl)benzo[b]thiophene-2-carboxylate, and (8) Ethyl 7-(trifluoromethyl)benzo[b]thiophene-2-carboxylate.

Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-A]pyrimidines as antidepressant agents

The present invention relates to certain novel substituted dihydroimidazo[2,1-b]thiazole and dihydro-5H-thiazolo[3,2-a]pyrimidine compounds of Formula (I) including pharmaceutically acceptable salts thereof in which have affinity for 5-HT1A receptors and which inhibits neuronal reuptake of 5-hydroxytryptamine and/or noradrenaline, to processes for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of depression, anxiety, psychoses (for example schizophrenia), tardive dyskinesia, obesity, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, obsessive-compulsive behaviour, panic attacks, social phobias, eating disorders such as bulimia, anorexia, snacking and binge eating, non-insulin dependent diabetes mellitus, hyperglycaemia, hyperlipidaemia, stress, as an aid to smoking cessation and in the treatment and/or prophylaxis of seizures, neurological disorders such as epilepsy and/or in which there is neurological damage such as stroke, brain trauma, cerebral ischaemia, head injuries and haemorrhage.